Increasing medical evidence suggests that erectile dysfunction (ED) can be highly correlated to heart and vascular disease. Several studies, including one co-authored by Allen D. Seftel, MD, FACS, Head, Division of Urology at Cooper University Hospital, conclude that ED in men over 40 is a clear indicator of future risk of cardiovascular disease.
“More than 30 million men in America suffer from ED,” says Dr. Seftel, a world-renowned expert in the field of male sexual medicine. “The goal of our program is to guide our patients through all aspects of their health, so we can treat their ED and hopefully prevent future health crises from occurring.”
COMPREHENSIVE MEDICAL AND SURGICAL CARE
Cooper’s Men’s Sexual Health Program provides comprehensive medical management of a full array of disorders including: benign prostatic hyperplasia (BPH), ED, Peyronie’s disease, premature ejaculation (PE) and low testosterone (hypogonadism).
Cooper’s urologists also specialize in bladder, kidney, urinary tract diseases and all other conditions treated by urologists in community and tertiary care settings.
“Dr. Seftel takes a very unique approach with his patients by connecting ED with other health concerns,” says Perry J. Weinstock, MD, FACC, Head, Division of Cardiovascular Disease. “Because he and his team take the time to do this, we have found profound, undiagnosed coronary artery disease in patients that resulted in life saving therapy.”
Cooper urologists offer comprehensive surgical services and excellent outcomes for treatment of ED. Treatment options range from penile prostheses and arterial revascularization to vacuum erection devices, penile injection therapy, and venous ligation surgery.
ED remains one of the most challenging side effects of prostate cancer treatment. Cooper offers the latest surgical options for disease treatment,including radical prostatectomies, external beam radiotherapy, brachytherapy, and androgen-deprived therapy. Dr. Seftel and the clinical team at Cooper Cancer Institute have developed a full spectrum of post-procedure interventions for penile rehabilitation.
The Active Surveillance Program works with men with low-risk clinically localized prostate cancer by providing close monitoring, digital rectal exams (DREs) and biopsies. Disease progression and patient choice determine if, when, and what type of treatment is indicated.
The Cooper urology team is active in clinical and basic science research,including studies in Peyronie’s disease, hypogonadism, enlarged prostate and the effects of radical prostatectomy on the return of male sexual function.
Michael E. DiSanto, PhD, Director of Urological Research is participating in an NIH grant to study the cell and molecular basis for smooth muscle function in the lower urogenital system. His research focuses on the molecular mechanisms for urogenital function and dysfunction with the goal of identifying novel pharmacotherapy to treat ED.
Joel M. Marmar, MD, FACS, Attending Surgeon, is a leader in the development of minimally invasive vasectomy, vasectomy reversal and sperm aspiration procedures and implements. His “In Line Vasectomy” requires an incision less than 1 cm and takes only five minutes per side compared to about 30 minutes per side for the traditional approach.
The procedure is gaining popularity throughout the world. Two years ago, Dr. Marmar taught his technique to India’s Master Trainer of Vasectomiesand Microsurgery, Dr. Ramachandra Murti Kaza who also serves as Principal Advisor, No Scalpel Vasectomy (NSV), Government of India and as Professor of Surgery, Maulana Azad Medical College, New Delhi. Since then, Dr. Kaza has begun teaching the technique and has performed over 300 cases himself. He reports that his colleagues are “picking up the procedure and enjoying it…The fact that mesentery of vas is not dissected makes a lot of difference.”
For more information, or to refer a patient, please call 856.342.5893.